FLAG PROTOCOL-BASED CURE RATE OF ACUTE MYELOID LEUKEMIA-Reference-Cited by-同舟云学术

FLAG PROTOCOL-BASED CURE RATE OF ACUTE MYELOID LEUKEMIA

Published:2011-12-28 Issue:2S Volume: Page:85-87
ISSN:2708-6011
Container-title:Health and Ecology Issues
language:
Short-container-title:jour

Author:

Tretyak N. N.¹,Goryainova N. V.¹,Kiseliova E. A.¹,Koval A. I.¹,Anoshina M. Yu.¹,Basova O. V.¹,Vakulchuk A. M.¹,Perehrestenko T. P.¹,Mnishenko V. N.¹

Affiliation:

1. Institute of Haematology and Transfusiology AMS Ukraine

Abstract

The article presents the results of our own fludarabin-containing FLAG protocol-based treatment of 54 patients with both first detected and resistant forms of acute myeloid leukemia. It has been shown that, the application of the indicated chemiotherapy scheme is highly effective and makes it possible to assure remission in most patients.

Publisher

Gomel State Medical University

Reference11 articles.

1. BIBLIOGRAFIChESKII SPISOK

2. Pharmacokinetics and pharmacodynamics studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusion / V. I. Avramis [et al.] // The Children Cancer Group. Clin. Cancer Res. - 1998. - Vol. 4(1). - P. 45-52.

3. Cortes, J. E. Defining the optimal dose schedule of purine analogs and assessment of response / J. E. Cortes, S. M. O’Brien; ed.: B. D. Cheson [et al.]. // Nucleoside analogs in cancer therapy. - New York: Marcel. Dekker. Inc. - 1997. - P. 175-200.

4. Gandhi, V. Cellular and clinical pharmacology of fludarabine / V. Gandhi, W. Plunkett // Clin. Pharmacokinet. - 2002. - Vol. 41. - P. 93-103.

5. Combination of fludarabine and arabinosylcytosine for the treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology / V. Gandhi [et al.] // Cancer Chem. Pharmacol. - 1994. - Vol. 34. - P. 30-36.